AR021009A1 - DISPOSITIVO RETENEDOR EN EL ESToMAGO CON COMPONENTE EXPANSIBLE Y UNA SUSTANCIA ACTIVA. - Google Patents

DISPOSITIVO RETENEDOR EN EL ESToMAGO CON COMPONENTE EXPANSIBLE Y UNA SUSTANCIA ACTIVA.

Info

Publication number
AR021009A1
AR021009A1 ARP990105450A ARP990105450A AR021009A1 AR 021009 A1 AR021009 A1 AR 021009A1 AR P990105450 A ARP990105450 A AR P990105450A AR P990105450 A ARP990105450 A AR P990105450A AR 021009 A1 AR021009 A1 AR 021009A1
Authority
AR
Argentina
Prior art keywords
active substance
stomach
retaining device
pylorus
incorporated
Prior art date
Application number
ARP990105450A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR021009A1 publication Critical patent/AR021009A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Un dispositivo para retardar el paso por el píloro, de formas medicamentosas ingeribles con un componente que puede expandirse al entrar en contacto conlos jugos gástricos y con una envoltura polimérica que es permeable a los líquidos peroimpermeabl e a los gases. El dispositivo puede contener una sustanciaactiva que es entregada en los jugos gástricos de manera controlada por la forma medicamentosa incorporada. A diferencia de las formas medicamentosasconvencionales con un pasoretardado por el píloro, la liberacion de la sustancia activa depende menos del tipo y aptitud de la envoltura polimérica, y esdeterminada predominantemente por la forma incorporada. El dispositivo de acuerdo con la invencion es fácil de laminar oplegar, y puede se r introducido encápsulas.
ARP990105450A 1998-10-30 1999-10-28 DISPOSITIVO RETENEDOR EN EL ESToMAGO CON COMPONENTE EXPANSIBLE Y UNA SUSTANCIA ACTIVA. AR021009A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19850309A DE19850309A1 (de) 1998-10-30 1998-10-30 Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer

Publications (1)

Publication Number Publication Date
AR021009A1 true AR021009A1 (es) 2002-06-12

Family

ID=7886319

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105450A AR021009A1 (es) 1998-10-30 1999-10-28 DISPOSITIVO RETENEDOR EN EL ESToMAGO CON COMPONENTE EXPANSIBLE Y UNA SUSTANCIA ACTIVA.

Country Status (23)

Country Link
US (1) US6776999B1 (es)
EP (1) EP1124534B1 (es)
JP (1) JP2002528482A (es)
KR (1) KR100654482B1 (es)
CN (1) CN1222274C (es)
AR (1) AR021009A1 (es)
AT (1) ATE257694T1 (es)
AU (1) AU758112B2 (es)
BR (1) BR9914841A (es)
CA (1) CA2344672C (es)
CZ (1) CZ293951B6 (es)
DE (2) DE19850309A1 (es)
DK (1) DK1124534T3 (es)
ES (1) ES2214915T3 (es)
HK (1) HK1040197B (es)
IL (1) IL142846A0 (es)
NZ (1) NZ510340A (es)
PL (1) PL194337B1 (es)
RU (1) RU2242219C2 (es)
TR (1) TR200101173T2 (es)
TW (1) TWI226246B (es)
WO (1) WO2000025742A1 (es)
ZA (1) ZA200102759B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19920838A1 (de) * 1999-05-06 2000-11-16 Lohmann Therapie Syst Lts Gastroretentives System mit Kapillaren
FR2827502B1 (fr) * 2001-07-17 2004-04-09 Univ Joseph Fourier Micromuscle en milieu biologique
US20080089933A1 (en) 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
US9205094B2 (en) 2006-12-22 2015-12-08 Ironwood Pharmaceuticals, Inc. Compositions comprising bile acid sequestrants for treating esophageal disorders
US7925351B2 (en) * 2007-06-13 2011-04-12 Betastim, Ltd. Gastrointestinal device for treating obesity and diabetes
US20090259246A1 (en) * 2008-04-14 2009-10-15 Sherif Eskaros Intragastric Volume-Occupying Device
WO2010110882A1 (en) * 2009-03-23 2010-09-30 Paolo Costa Absorption barrier and method of using the same
US8414559B2 (en) 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
US9421169B2 (en) * 2009-11-20 2016-08-23 Covidien Lp Oral dosage forms for delivery of therapeutic agents
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US8722066B2 (en) 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
WO2013183058A2 (en) 2012-06-07 2013-12-12 Tulip Medical Ltd. Expanded device
WO2015083171A1 (en) 2013-12-05 2015-06-11 Tulip Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
CN106573015B (zh) 2014-06-11 2021-11-26 麻省理工学院 肠溶弹性体
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3364946A4 (en) 2015-10-23 2019-06-26 Lyndra, Inc. STOMACH DISTRIBUTION SYSTEMS FOR DELAYED RELEASE OF THERAPEUTIC ACTIVE SUBSTANCES AND METHOD FOR THEIR USE
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
WO2018064630A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
EP3547974B1 (en) * 2016-12-02 2023-11-15 Clexio Biosciences Ltd. Gastric residence system
CN112618094B (zh) * 2020-12-15 2021-12-10 上海澎立生技医药研究有限公司 一种脑梗的颈静脉插管给药装置

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901232A (en) * 1973-10-26 1975-08-26 Alza Corp Integrated device for administering beneficial drug at programmed rate
US3944064A (en) * 1973-10-26 1976-03-16 Alza Corporation Self-monitored device for releasing agent at functional rate
US4036228A (en) 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
GB1518364A (en) 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4235236A (en) 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
GB8305797D0 (en) 1983-03-02 1983-04-07 Graham N B Hydrogel-containing envelopes
EP0147780A3 (en) 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPS6226215A (ja) * 1985-05-10 1987-02-04 メルク　エンド　カムパニ−　インコ−ポレ−テツド 一定に制御した時間内胃中に保持できる薬剤移送装置
US4758436A (en) 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
JPS6251141A (ja) * 1985-08-29 1987-03-05 Hitachi Ltd Ｘ線発生装置
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
JPS62207209A (ja) 1986-03-07 1987-09-11 Teijin Ltd 経口徐放性製剤
US4847093A (en) * 1986-06-19 1989-07-11 Alza Corporation Dosage form with means for governing rate of gas formation
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
JPH0261934A (ja) * 1988-08-29 1990-03-01 Hitachi Ltd カラー受像管用パネルの製造方法
JPH03163011A (ja) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
JP3012667B2 (ja) * 1990-06-04 2000-02-28 大日本製薬株式会社 液体浮遊性中空材料
EP0961611B1 (de) * 1997-01-14 2002-03-27 LTS Lohmann Therapie-Systeme AG Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt
SE9702533D0 (sv) * 1997-07-01 1997-07-01 Astra Ab New oral formulation

Also Published As

Publication number Publication date
CN1324232A (zh) 2001-11-28
TWI226246B (en) 2005-01-11
CZ20011478A3 (cs) 2001-08-15
CN1222274C (zh) 2005-10-12
CA2344672C (en) 2008-07-29
NZ510340A (en) 2003-01-31
EP1124534A1 (de) 2001-08-22
US6776999B1 (en) 2004-08-17
CZ293951B6 (cs) 2004-08-18
EP1124534B1 (de) 2004-01-14
IL142846A0 (en) 2002-03-10
AU758112B2 (en) 2003-03-13
AU1153700A (en) 2000-05-22
KR20010082259A (ko) 2001-08-29
JP2002528482A (ja) 2002-09-03
ZA200102759B (en) 2001-10-22
PL348155A1 (en) 2002-05-06
PL194337B1 (pl) 2007-05-31
HK1040197A1 (en) 2002-05-31
HK1040197B (zh) 2006-02-17
CA2344672A1 (en) 2000-05-11
DE19850309A1 (de) 2000-05-04
WO2000025742A1 (de) 2000-05-11
TR200101173T2 (tr) 2001-10-22
DK1124534T3 (da) 2004-05-03
KR100654482B1 (ko) 2006-12-05
DE59908319D1 (de) 2004-02-19
BR9914841A (pt) 2001-07-10
ATE257694T1 (de) 2004-01-15
RU2242219C2 (ru) 2004-12-20
ES2214915T3 (es) 2004-09-16

Similar Documents

Publication Publication Date Title
AR021009A1 (es) DISPOSITIVO RETENEDOR EN EL ESToMAGO CON COMPONENTE EXPANSIBLE Y UNA SUSTANCIA ACTIVA.
ES2040789T3 (es) Formas de administracion retardantes envueltas.
ES2175676T3 (es) Sistema terapeutico expansible de retencion gastrica con liberacion controlada de principio activo en el tracto gastrointestinal.
CO4920217A1 (es) Comprimido de liberacion controlada de clorhidrato de alfuzosina
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
ATE264666T1 (de) Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe
AR039037A1 (es) Un sistema de liberacion de una droga vaginal con un ph esencialmente neutro y un metodo para tratar una enfermedad vaginal que comprende dicho sistema
DE60101581D1 (de) Tablettenform zur gastrischen zurückhaltungssteigerung wasserquellfähiger mit kontrollierter freisetzung oraler dosierungsformen
AR030557A1 (es) Una tableta en multicapa de liberacion controlada y metodo de tratamiento
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
ES2023649B3 (es) Formas de dosificacion y administracion para medicamentos, reactivos o similares asi como procedimiento para su obtencion.
GB2451364A (en) Vaginal drug delivery system and method
TR199701083T1 (xx) Transdermal uygulama i�in farmas�tik kompozisyon.
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
ES2044825T1 (es) Formulaciones de matriz de liberacion sostenida.
ES2111547T3 (es) Comprimido de liberacion prolongada.
CL2007002000A1 (es) Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion.
AR032642A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponibilidad oral.
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
BR112012006056A2 (pt) forma de dosagem
AR036085A1 (es) Formas de dosificacion y procedimiento para su fabricacion
BR0314787A (pt) Forma de dosagem de liberação modificada
AR044939A1 (es) Sistema de administracion para medicaciones topicas
CR8948A (es) Composicion farmaceutica

Legal Events

Date Code Title Description
FG Grant, registration